Rain Therapeutics Inc. (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States ,Joe Catanzaro ,Tony Butler ,Sam Slutsky ,Mitchell Kapoor ,Yigal Nochomovitz ,Nelson Cabatuan ,Richard Bryce ,Graig Suvannavejh ,Robert Doebele ,Michael Schmidt ,Faisal Khurshid ,Bob Doebele ,Piper Sandler ,Jeff Jones ,Avantika Joshi ,Avanish Vellanki ,Soumit Roy ,Memorial Sloan Kettering Cancer Center ,Rain Oncology Inc ,Nasdaq ,Exchange Commission ,Rain Therapeutics Inc ,Citigroup ,Brain Therapeutics ,Call Transcript May ,Rain Oncology ,First Quarter ,Chief Executive Officer ,Chief Scientific Officer ,Chief Medical Officer ,Private Securities Litigation Reform Act ,Clinical Oncology ,